IP Library Granted Patent US 10,036,011
Granted Patent B2
US 10,036,011 · App. 15/427,832 · Granted Jul 31, 2018

Scavenger compounds for improved sequencing-by-synthesis

Inventor: Luisa Andruzzi (Concord, MA)
Assignee: QIAGEN Waltham, INC.
C12N15/1068
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,036,011
App. No.
15/427,832
Granted
Jul 31, 2018
Kind
B2
Abstract

The present invention discloses methods of applications of indole-3-propionic acid, L-carnitine and O-acetyl-L-carnitine in one or more different reactive steps of a sequencing-by-synthesis workflow. The reactive steps employing these compounds include, but are not limited to, cleaving, imaging, incorporating bases and washing. The use of these new compounds provides improved sequencing performance including, but not limited to, lower error rates, higher sequence outputs and/or longer read lengths.

Claims (56)

1. A method of incorporating labeled nucleotides, comprising:

a) providing i) a plurality of nucleic acid primers and template molecules, ii) a polymerase, iii) a cleave reagent comprising a scavenger selected from the group consisting of indole-3-propionic acid and a carnitine-based compound, and iv) a plurality of nucleotide analogues wherein at least a portion of said nucleotide analogues is labeled with a label attached through a cleavable disulfide linker to the base;

b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers;

c) incorporating a first labeled nucleotide analogue with said polymerase into at least a portion of said hybridized primers so as to create extended primers comprising an incorporated nucleotide analogue; and

d) cleaving the cleavable linker of said incorporated nucleotide analogues with said cleave reagent.

2. The method of claim 1 , wherein said scavenger is indole-3-propionic acid.

3. The method of claim 1 , wherein said scavenger is L-carnitine.

4. The method of claim 1 , wherein said scavenger is O-acetyl-L-carnitine.

5. The method of claim 1 , wherein said incorporated nucleotide analogues of step c) further comprise a removable chemical moiety capping the 3′-OH group.

6. The method of claim 5 , wherein the cleaving of step d) removes the removable chemical moiety capping the 3′-OH group.

7. The method of claim 6 , wherein the method further comprises:

d) incorporating a second nucleotide analogue with said polymerase into at least a portion of said extended primers.

8. The method of claim 7 , wherein said incorporating of a second nucleotide analogue is performed in the presence of a scavenger selected from the group consisting of indole-3-propionic acid and a carnitine-based compound.

9. A method of incorporating nucleotides, comprising:

a) providing i) a plurality of nucleic acid primers and template molecules, and ii) an extend reagent, said extend reagent comprising polymerase, a plurality of nucleotide analogues, and a scavenger selected from the group consisting of indole-3-propionic acid and a carnitine-based compound;

b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers; and

c) exposing said hybridized primers to said extend reagent under conditions such that a first nucleotide analogue is incorporated into at least a portion of said hybridized primers so as to create extended primers comprising an incorporated nucleotide analogue.

10. The method of claim 9 , wherein said incorporated nucleotide analogue comprises a label attached through a cleavable disulfide linker to the base.

11. The method of claim 10 , wherein said label is fluorescent.

12. The method of claim 9 , wherein said extend reagent further comprises cystamine.

13. The method of claim 10 , further comprising:

d) cleaving the cleavable linker of said incorporated nucleotide analogue with a cleave reagent comprising a scavenger selected from the group consisting of indole-3-propionic acid and a carnitine-based compound.

14. The method of claim 9 , wherein said scavenger is indole-3-propionic acid.

15. The method of claim 9 , wherein said scavenger is L-carnitine.

16. The method of claim 9 , wherein said scavenger is O-acetyl-L-carnitine.

17. The method of claim 13 , wherein said incorporated nucleotide analogues prior to step d) further comprise a removable chemical moiety capping the 3′-OH group.

18. The method of claim 17 , wherein the cleaving of step d) removes the removable chemical moiety capping the 3′-OH group.

19. A method of incorporating nucleotides, comprising:

a) providing i) a plurality of nucleic acid primers and template molecules, ii) an extend reagent comprising polymerase and a plurality of nucleotide analogues, and iii) a wash reagent comprising a scavenger selected from the group consisting of indole-3-propionic acid and a carnitine-based compound;

b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers;

c) exposing said hybridized primers to said extend reagent under conditions such that a first nucleotide analogue is incorporated into at least a portion of said hybridized primers so as to create extended primers comprising an incorporated nucleotide analogue;

d) washing said extended primers with said wash reagent.

20. The method of claim 19 , wherein said incorporated nucleotide analogue comprises a label attached through a cleavable disulfide linker to the base.

21. The method of claim 20 , wherein said label is fluorescent.

22. The method of claim 20 , wherein said extend reagent further comprises cystamine.

23. The method of claim 20 , further comprising:

e) detecting said label of a first labeled nucleotide analogue.

24. The method of claim 23 , wherein said detecting of step e) is performed in the presence of a scavenger selected from the group consisting of indole-3-propionic acid and a carnitine-based compound.

25. The method of claim 19 , wherein said scavenger is indole-3-propionic acid.

26. The method of claim 19 , wherein said scavenger is L-carnitine.

27. The method of claim 19 , wherein said scavenger is O-acetyl-L-carnitine.

28. A method of incorporating labeled nucleotides, comprising:

a) providing i) a plurality of nucleic acid primers and template molecules, ii) an extend reagent comprising polymerase and a plurality of nucleotide analogues wherein at least a portion of said nucleotide analogues is labeled, and iii) an image reagent comprising a scavenger selected from the group consisting of indole-3-propionic acid and a carnitine-based compound;

b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers;

c) exposing said hybridized primers to said extend reagent under conditions such that a first labeled nucleotide analogue is incorporated into at least a portion of said hybridized primers so as to create extended primers comprising an incorporated nucleotide analogue; and

d) detecting said label of said first labeled nucleotide analogue with said image reagent.

29. The method of claim 28 , wherein said label is attached through a cleavable disulfide linker to the base.

30. The method of claim 29 , wherein said label is fluorescent.

31. The method of claim 28 , wherein said extend reagent further comprises cystamine.

32. The method of claim 29 , further comprising:

e) cleaving the cleavable linker of said incorporated nucleotide analogue with a cleave reagent comprising a scavenger selected from the group consisting of indole-3-propionic acid and a carnitine-based compound.

33. The method of claim 28 , wherein said scavenger is indole-3-propionic acid.

34. The method of claim 28 , wherein said scavenger is L-carnitine.

35. The method of claim 28 , wherein said scavenger is O-acetyl-L-carnitine.

36. The method of claim 32 , wherein said incorporated labeled nucleotide analogue of step d) further comprises a removable chemical moiety capping the 3′-OH group.

37. The method of claim 36 , wherein the cleaving of step e) removes the removable chemical moiety capping the 3′-OH group.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
MERGER Recorded Jul 30, 2021
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 057046/0140 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2017
From: ANDRUZZI, LUISA
To: QIAGEN WALTHAM, INC.
Reel/Frame 044407/0657 →
Continuity (2)
Provisional Application 62293969 · Feb 11, 2016
Related Publication 20170233725A1 · Aug 17, 2017